Subsequently, suppression of BARX1 by ZFP36 led to downregulation of the BARX1 downstream targets, thereby suppressing NSCLC cell proliferation, migration and invasion in vitro and tumorigenicity in mouse xenografts. Here, ZFP36 is linked to non-small cell lung carcinoma.